Outsourcing Management in the Pharmaceutical Industry: The Early Stages at Four United States Companies

被引：0

作者：

Debbie A. Daniel

Nanette Nanjo-Jones

James Kirwin

Sue A. Stempien

机构：

[1] The R. W. Johnson Pharmaceutical Research Institute,Central Contracts and Grants, Finance, Planning and Lab Services

[2] Genentech,Department of Medical Affairs Finance

[3] Inc.,Clinical Medical Affairs

[4] Zeneca Pharmaceuticals,Department of Finance

[5] Roche Bioscience,undefined

[6] a division of Syntex (U.S.A.) Inc.,undefined

来源：

Drug information journal : DIJ / Drug Information Association | 1997年 / 31卷 / 1期

关键词：

Outsourcing; Virtual drug development; Contract research organizations; Centralized negotiation; Contract;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The authors have been involved with initial concept development and implementation of the outsourcing management process at their respective companies. Representing three large global pharmaceutical companies and one large biotechnology company, they will discuss outsourcing management at their companies, how it developed, and where it seems to be headed on the road to virtual drug development.

引用

页码：111 / 118

页数：7

共 50 条

[31] Where Does the Pharmaceutical Industry Spend Its Money? Evaluation of Industry Payments to Gastroenterologists Across the United States
Harewood, Gavin C.
Ryan, Tim
Lewis, Sarah N.
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S183 - S183
[32] The Impact of the Early Stages of COVID-19 on Mental Health in the United States, Germany, and the United Kingdom
Mueller, Sandrine R.
Delahunty, Fionn
Matz, Sandra C.
[J]. JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 2023, 124 (03) : 620 - 639
[33] Water resource use and management by the United States forest products industry
Wiegand, P. S.
Flinders, C. A.
Ice, G. G.
Malmberg, B. J.
Fisher, R. P.
[J]. WATER SCIENCE AND TECHNOLOGY, 2009, 60 (03) : 751 - 760
[34] RATES OF RETURN ON RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL-INDUSTRY - UNITED-STATES VERSUS UK
SIMMONS, SA
SHULL, SC
SMITH, MC
[J]. MANAGEMENT INTERNATIONAL REVIEW, 1981, 21 (04) : 62 - 72
[35] PRICING, REGULATION, AND COMPETITIVENESS - LESSONS FOR THE UNITED-STATES FROM THE JAPANESE PHARMACEUTICAL-INDUSTRY
THOMAS, LG
[J]. PHARMACOECONOMICS, 1994, 6 : 67 - 70
[36] THE ROLE OF THE RESEARCH-BASED PHARMACEUTICAL-INDUSTRY IN MEDICAL PROGRESS IN THE UNITED-STATES
KAITIN, KI
BRYANT, NR
LASAGNA, L
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (05): : 412 - 417
[37] Challenges creating monarch butterfly management strategies for electric power companies in the United States
Fox, Jessica
Allen, Kasey
Diffendorfer, Jay E.
Lukens, Laura
Thogmartin, Wayne E.
Newman, Christian
[J]. FRONTIERS IN ECOLOGY AND EVOLUTION, 2024, 12
[38] INTEGRATED PEST-MANAGEMENT - ITS IMPACT ON UNITED-STATES AGROCHEMICAL COMPANIES
HOCH, PE
[J]. CHEMISTRY & INDUSTRY, 1979, (22) : 783 - 788
[39] A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation
Davis, Courtney
Abraham, John
[J]. HEALTH RISK & SOCIETY, 2011, 13 (05) : 413 - 431
[40] PREVALENCE OF ENTEROPATHOGENS IN FOUR MANAGEMENT MODELS FOR UNOWNED CATS IN THE SOUTHEAST UNITED STATES
Andersen, L. A.
Levy, J. K.
McManus, C. M.
McGorray, S. P.
Leutenegger, C. M.
[J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2011, 25 (03) : 709 - 709

← 1 2 3 4 5 →